B cell biomarkers of rituximab responses in systemic lupus erythematosus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

B cell biomarkers of rituximab responses in systemic lupus erythematosus

Published:2011-09-27 Issue:10 Volume:63 Page:3038-3047
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Vital Edward M.,Dass Shouvik,Buch Maya H.,Henshaw Karen,Pease Colin T.,Martin Michael F.,Ponchel Frederique,Rawstron Andrew C.,Emery Paul

Funder

National Institute for Health Research (NIHR) Research Training Fellowship

NIHR Clinician Scientist Award

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.30466/fullpdf

Reference22 articles.

1. The Euro-lupus project: epidemiology of systemic lupus erythematosus in Europe;Cervera;Lupus,2009

2. Systemic lupus erythematosus;Rahman;N Engl J Med,2008

3. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks;Cohen;Arthritis Rheum,2006

4. Reduction of fatigue in Sjögren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study;Dass;Ann Rheum Dis,2008

5. Rituximab versus cyclophosphamide for ANCA-associated vasculitis;Stone;N Engl J Med,2010

Cited by 196 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Future directions;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Anti-B-Cell-Activating Factor (BAFF) Therapy: A Novel Addition to Autoimmune Disease Management and Potential for Immunomodulatory Therapy in Warm Autoimmune Hemolytic Anemia;Biomedicines;2024-07-18

3. European flow cytometry quality assurance guidelines for the diagnosis of primary immune deficiencies and assessment of immune reconstitution following B cell depletion therapies and transplantation;Cytometry Part B: Clinical Cytometry;2024-06-28

4. Sustained depression of B cell counts in lupus nephritis after treatment with rituximab and/or belimumab is associated with fewer disease flares;Lupus;2024-06-11

5. A Phase 1, randomized, double-blind, placebo-controlled, single- and multiple-dose escalation study to evaluate the safety and pharmacokinetics/pharmacodynamics of PF-06835375, a C-X-C chemokine receptor type 5 directed antibody, in patients with systemic lupus erythematosus or rheumatoid arthritis;Arthritis Research & Therapy;2024-06-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3